ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
Martin37
|
150 |
55K |
9 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
150
|
55K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
Martin37
|
82 |
25K |
3 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
82
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
Martin37
|
82 |
25K |
9 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
82
|
25K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
BLA resubmission for children with SR-aGVHD
|
|
Martin37
|
52 |
22K |
9 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
52
|
22K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Martin37
|
17K |
6.8M |
22 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
17K
|
6.8M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Martin37
|
17K |
6.8M |
59 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
17K
|
6.8M
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Martin37
|
17K |
6.8M |
27 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
17K
|
6.8M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Martin37
|
6 |
2.7K |
16 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
6
|
2.7K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Martin37
|
1.1K |
350K |
31 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
1.1K
|
350K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Martin37
|
1.1K |
350K |
18 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
1.1K
|
350K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Martin37
|
190 |
62K |
6 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
190
|
62K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Martin37
|
190 |
62K |
22 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
190
|
62K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Martin37
|
778 |
282K |
13 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
778
|
282K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
Martin37
|
202 |
85K |
37 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
202
|
85K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Martin37
|
1.0K |
331K |
87 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
1.0K
|
331K
|
87
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
Martin37
|
144 |
56K |
15 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
144
|
56K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
Martin37
|
144 |
56K |
17 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
144
|
56K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
Martin37
|
144 |
56K |
35 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
144
|
56K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Who engineered 14M dump in the auction and how
|
|
Martin37
|
20 |
8.5K |
19 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
20
|
8.5K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MSB - Maximum Market Size
|
|
Martin37
|
68 |
22K |
10 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
68
|
22K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Martin37
|
5.5K |
2.7M |
35 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
5.5K
|
2.7M
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Martin37
|
4.7K |
1.1M |
12 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Appoints Dr Eric Rose as Chief Medical Officer
|
|
Martin37
|
147 |
42K |
21 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
147
|
42K
|
21
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
Martin37
|
1.5K |
507K |
19 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
1.5K
|
507K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
Martin37
|
41 |
10K |
7 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
Martin37
|
41 |
10K |
30 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
Martin37
|
41 |
10K |
8 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
Martin37
|
41 |
10K |
13 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
Martin37
|
41 |
10K |
20 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Martin37
|
1.1K |
350K |
10 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
1.1K
|
350K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
Martin37
|
267 |
64K |
11 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
Martin37
|
267 |
64K |
31 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
Martin37
|
267 |
64K |
31 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Martin37
|
17K |
6.8M |
22 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
17K
|
6.8M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Martin37
|
880 |
215K |
22 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
880
|
215K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Martin37
|
880 |
215K |
17 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
215K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Martin37
|
4.7K |
1.1M |
8 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Martin37
|
880 |
215K |
16 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
215K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Martin37
|
4.7K |
1.1M |
16 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Martin37
|
880 |
215K |
20 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
215K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Martin37
|
880 |
215K |
14 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
215K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Martin37
|
880 |
215K |
30 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
215K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Martin37
|
4.7K |
1.1M |
28 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
Martin37
|
373 |
88K |
31 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
373
|
88K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
Martin37
|
373 |
88K |
25 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
88K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
Martin37
|
373 |
88K |
38 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
88K
|
38
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
Martin37
|
373 |
88K |
16 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
88K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Martin37
|
5.5K |
2.7M |
49 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
5.5K
|
2.7M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Martin37
|
211 |
73K |
56 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
73K
|
56
|
|
ASX - By Stock
|
MSB |
Re:
Melbourne to become stem cell research world centre
|
|
Martin37
|
7 |
2.7K |
8 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
7
|
2.7K
|
8
|
|